Literature DB >> 31349902

Cancer stem cells in breast and prostate: Fact or fiction?

Rocío G Sampayo1, Mina J Bissell2.   

Abstract

Since the introduction of the cancer stem cell (CSC) hypothesis, accumulating evidence shows that most cancers present stem-like niches. However, therapies aimed at targeting this niche have not been as successful as expected. New evidence regarding CSCs hierarchy, similarities with normal tissue stem cells and cell plasticity might be key in understanding their role in cancer biology and how to efficiently eliminate them. In this Chapter, we discuss what is known in breast and prostate CSCs from their initial discoveries to the current therapeutic efforts in the field. Future challenges towards better CSC identification and isolation strategies will be key to shed light into how CSCs could accurately be targeted in combination to traditional therapies to ultimately prolong patient survival.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast; Cancer stem cells; Hierarchy; Markers; Prostate

Mesh:

Substances:

Year:  2019        PMID: 31349902      PMCID: PMC7314432          DOI: 10.1016/bs.acr.2019.03.010

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  159 in total

1.  The unmasking of novel unipotent stem cells in the mammary gland.

Authors:  Jane E Visvader; Geoffrey J Lindeman
Journal:  EMBO J       Date:  2011-11-08       Impact factor: 11.598

2.  Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status.

Authors:  Renea A Taylor; Roxanne Toivanen; Mark Frydenberg; John Pedersen; Laurence Harewood; Anne T Collins; Norman J Maitland; Gail P Risbridger
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

3.  Cancer stem cells: moving past the controversy.

Authors:  Justin D Lathia
Journal:  CNS Oncol       Date:  2013-11

Review 4.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

5.  Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer.

Authors:  Balraj Singh; Kendra R Cook; Cecilia Martin; Eugene H Huang; Kailash Mosalpuria; Savitri Krishnamurthy; Massimo Cristofanilli; Anthony Lucci
Journal:  Clin Exp Metastasis       Date:  2010-03-13       Impact factor: 5.150

Review 6.  In search of a stem cell hierarchy in the human breast and its relevance to breast cancer evolution.

Authors:  René Villadsen
Journal:  APMIS       Date:  2005 Nov-Dec       Impact factor: 3.205

Review 7.  Breast tumor heterogeneity: cancer stem cells or clonal evolution?

Authors:  Lauren L Campbell; Kornelia Polyak
Journal:  Cell Cycle       Date:  2007-08-17       Impact factor: 4.534

8.  CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.

Authors:  P-K Lo; D Kanojia; X Liu; U P Singh; F G Berger; Q Wang; H Chen
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

9.  Evidence for a stem cell hierarchy in the adult human breast.

Authors:  René Villadsen; Agla J Fridriksdottir; Lone Rønnov-Jessen; Thorarinn Gudjonsson; Fritz Rank; Mark A LaBarge; Mina J Bissell; Ole W Petersen
Journal:  J Cell Biol       Date:  2007-04-09       Impact factor: 10.539

Review 10.  New Findings on Breast Cancer Stem Cells: A Review.

Authors:  Azam Bozorgi; Mozafar Khazaei; Mohammad Rasool Khazaei
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

View more
  7 in total

1.  TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis.

Authors:  Michaela Galoczova; Rudolf Nenutil; Zuzana Pokorna; Borivoj Vojtesek; Philip J Coates
Journal:  Virchows Arch       Date:  2020-10-10       Impact factor: 4.064

2.  lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells.

Authors:  Kimberly A Parker; Alex J Gooding; Saba Valadkhan; William P Schiemann
Journal:  Mol Cancer Res       Date:  2021-09-08       Impact factor: 5.852

Review 3.  Interaction between prostate cancer stem cells and bone microenvironment regulates prostate cancer bone metastasis and treatment resistance.

Authors:  Lu Yao; Xiangyu Zhang
Journal:  J Cancer       Date:  2022-06-13       Impact factor: 4.478

4.  Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer.

Authors:  Bide Liu; Xun Li; Jiuzhi Li; Hongyong Jin; Hongliang Jia; Xiaohu Ge
Journal:  Dis Markers       Date:  2020-10-09       Impact factor: 3.434

Review 5.  Dual or multiple drug loaded nanoparticles to target breast cancer stem cells.

Authors:  Yu Gao; Mingtan Tang; Euphemia Leung; Darren Svirskis; Andrew Shelling; Zimei Wu
Journal:  RSC Adv       Date:  2020-05-19       Impact factor: 4.036

6.  microRNA-497 prevents pancreatic cancer stem cell gemcitabine resistance, migration, and invasion by directly targeting nuclear factor kappa B 1.

Authors:  Qiangfeng Yu; Zhe Xiu; Yizeng Jian; Jianyin Zhou; Xiaopeng Chen; Xiang Chen; Chunxiang Chen; Hongbao Chen; Sijia Yang; Libo Yin; Wenlong Zeng
Journal:  Aging (Albany NY)       Date:  2022-07-25       Impact factor: 5.955

Review 7.  The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.

Authors:  Teow J Phua
Journal:  Medicines (Basel)       Date:  2021-06-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.